These immune-related patterns are clinically relevant because aplastic anemia illustrates how CHIP-associated mutations reshape hematopoiesis and immune surveillance, themes that recur in the systemic effects of CHIP across cardiometabolic disorders through chronic inflammation and altered immune function [37]. Here, STUB1 is linked to aplastic anemia.